XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.2
Note 5 - Investment in Foreign Joint Venture - Schedule of Activity in Investment in Foreign Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Balance     $ 11,659    
Income from Equity Investment $ 120 $ 340 537 $ 587  
Less: dividend distributions     (1,637) $ (1,716)  
Balance 10,760   10,760    
Original basis difference 1,165   1,165   $ 1,165
Less accumulated accretion (767)   (767)   (702)
Net remaining basis difference at end of period 398   398   $ 463
Bomay [Member]          
Balance, initial investment [1],[2],[3],[4]     9,333    
Balance, undistributed earnings     3,021    
Balance, foreign exchange translation     (695)    
Balance     11,659    
Income from Equity Investment     537    
Income from Equity Investment     537    
Less: dividend distributions     (1,637)    
Foreign currency translation gain (loss)     201    
Balance, initial investment [1],[2],[3],[4] 9,333   9,333    
Balance, undistributed earnings 1,921   1,921    
Balance, foreign exchange translation (494)   (494)    
Balance $ 10,760   $ 10,760    
[1] Accumulated statutory reserves in equity method investments of $2.7 million at June 30, 2025 and December 31, 2024 is included in our investment in BOMAY. In accordance with the People’s Republic of China, (“PRC”) regulations on enterprises with foreign ownership, an enterprise established in the PRC with foreign ownership is required to provide for certain statutory reserves, namely (i) General Reserve Fund, (ii) Enterprise Expansion Fund and (iii) Staff Welfare and Bonus Fund, which are appropriated from net profit as reported in the enterprise’s PRC statutory accounts. A non-wholly-owned foreign invested enterprise is permitted to provide for the above allocation at the discretion of its board of directors. The aforementioned reserves can only be used for specific purposes and are not distributable as cash dividends.
[2] Accumulated statutory reserves in equity method investments of $2.7 million at March 31, 2025 and December 31, 2024 is included in our investment in BOMAY. In accordance with the People’s Republic of China, (“PRC”) regulations on enterprises with foreign ownership, an enterprise established in the PRC with foreign ownership is required to provide for certain statutory reserves, namely (i) General Reserve Fund, (ii) Enterprise Expansion Fund and (iii) Staff Welfare and Bonus Fund, which are appropriated from net profit as reported in the enterprise’s PRC statutory accounts. A non-wholly-owned foreign invested enterprise is permitted to provide for the above allocation at the discretion of its board of directors. The aforementioned reserves can only be used for specific purposes and are not distributable as cash dividends.
[3] The Company’s initial investment in BOMAY differed from the Company’s 40% share of BOMAY’s equity as a result of applying fair value accounting pursuant to ASC 805. The basis difference is being accreted over an original period of nine years (the expected life of the joint venture). The Company's accretion during the six months ended June 30, 2025 and 2024 both totaled approximately $65 thousand each, respectively, and is included in income from equity investment in foreign joint venture in the accompanying Condensed Consolidated Statements of Operations. The remaining basis difference, net of accumulated accretion at June 30, 2025 and December 31, 2024 is summarized in the following table (in thousands):
[4] The Company’s initial investment in BOMAY differed from the Company’s 40% share of BOMAY’s equity as a result of applying fair value accounting pursuant to ASC 805. The basis difference is being accreted over an original period of nine years (the expected life of the joint venture). The Company's accretion during the three months ended March 31, 2025 and 2024 both totaled approximately $32 thousand each, respectively, and is included in income from equity investment in foreign joint venture in the accompanying Condensed Consolidated Statements of Operations. The remaining basis difference, net of accumulated accretion at March 31, 2025 and December 31, 2024 is summarized in the following table (in thousands):